Protagonist Therapeutics
PTGX
#2251
Rank
โ‚น734.29 B
Marketcap
โ‚น11,250
Share price
-2.11%
Change (1 day)
47.04%
Change (1 year)

Earnings for Protagonist Therapeutics (PTGX)

Earnings in 2026 (TTM): โ‚น8.46 Billion

According to Protagonist Therapeutics 's latest financial reports the company's current earnings are โ‚น0.28 Billion. In 2025 the company made an earning of -โ‚น11.99 Billion a decrease over its 2024 earnings that were of โ‚น25.89 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protagonist Therapeutics from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น8.46 B-170.65%
2025 -โ‚น11.99 Billion-146.28%
2024 โ‚น25.89 B-453.88%
2023 -โ‚น7.32 Billion-38.02%
2022 -โ‚น11.81 Billion1.47%
2021 -โ‚น11.64 Billion93.62%
2020 -โ‚น6.01 Billion-16.74%
2019 -โ‚น7.22 Billion96.06%
2018 -โ‚น3.69 Billion7.48%
2017 -โ‚น3.43 Billion-0.59%
2016 -โ‚น3.45 Billion150.22%
2015 -โ‚น1.38 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น14.47 Billion-285.13%๐Ÿ‡บ๐Ÿ‡ธ USA